Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9227453rdf:typepubmed:Citationlld:pubmed
pubmed-article:9227453lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:9227453lifeskim:mentionsumls-concept:C0015259lld:lifeskim
pubmed-article:9227453lifeskim:mentionsumls-concept:C1158366lld:lifeskim
pubmed-article:9227453lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:9227453pubmed:issue6 Pt 1lld:pubmed
pubmed-article:9227453pubmed:dateCreated1997-8-18lld:pubmed
pubmed-article:9227453pubmed:abstractTextIn the present study we examined the hypothesis that fatty acid oxidation is less during high-intensity exercise than during moderate-intensity exercise because of inhibition of long-chain fatty acid entry into the mitochondria. Six volunteers exercised at 40% peak oxygen consumption (VO2peak) for 60 min and at 80% VO2peak for 30 min on two different occasions. [1-13C]oleate, a long-chain fatty acid, and [1-14C]octanoate, a medium-chain fatty acid, were infused for the duration of the studies. Lipids and heparin were infused during exercise at 80% VO2peak to prevent the expected decrease in plasma free fatty acid (FFA) concentration. Plasma oleate and total FFA availability were similar in the two experiments. Oleate oxidation decreased from 2.8 +/- 0.6 (40% VO2peak) to 1.8 +/- 0.2 mumol.kg-1.min-1 (80% VO2peak, P < 0.05), whereas octanoate oxidation increased from 1.0e-05 +/- 1.0e-06 (40% VO2peak) to 1.3e-05 +/- 5.1e-06 mumol.kg-1.min-1 (80% VO2peak, P < 0.05). Furthermore, the percentage of oleate uptake oxidized decreased from 67.7 +/- 2.8% (40% VO2peak) to 51.8 +/- 4.6% (80% VO2peak, P < 0.05), whereas the percentage of octanoate oxidized was similar during exercise at 40 and 80% VO2peak (84.8 +/- 2.7 vs. 89.3 +/- 2.7%, respectively). Our data suggest that, in addition to suboptimal FFA availability, fatty acid oxidation is likely limited during high-intensity exercise because of direct inhibition of long-chain fatty acid entry into mitochondria.lld:pubmed
pubmed-article:9227453pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9227453pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9227453pubmed:languageenglld:pubmed
pubmed-article:9227453pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9227453pubmed:citationSubsetIMlld:pubmed
pubmed-article:9227453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9227453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9227453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9227453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9227453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9227453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9227453pubmed:statusMEDLINElld:pubmed
pubmed-article:9227453pubmed:monthJunlld:pubmed
pubmed-article:9227453pubmed:issn0002-9513lld:pubmed
pubmed-article:9227453pubmed:authorpubmed-author:KleinSSlld:pubmed
pubmed-article:9227453pubmed:authorpubmed-author:WolfeR RRRlld:pubmed
pubmed-article:9227453pubmed:authorpubmed-author:SidossisL SLSlld:pubmed
pubmed-article:9227453pubmed:authorpubmed-author:GastaldelloKKlld:pubmed
pubmed-article:9227453pubmed:issnTypePrintlld:pubmed
pubmed-article:9227453pubmed:volume272lld:pubmed
pubmed-article:9227453pubmed:ownerNLMlld:pubmed
pubmed-article:9227453pubmed:authorsCompleteYlld:pubmed
pubmed-article:9227453pubmed:paginationE1065-70lld:pubmed
pubmed-article:9227453pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:9227453pubmed:meshHeadingpubmed-meshheading:9227453-...lld:pubmed
pubmed-article:9227453pubmed:meshHeadingpubmed-meshheading:9227453-...lld:pubmed
pubmed-article:9227453pubmed:meshHeadingpubmed-meshheading:9227453-...lld:pubmed
pubmed-article:9227453pubmed:meshHeadingpubmed-meshheading:9227453-...lld:pubmed
pubmed-article:9227453pubmed:meshHeadingpubmed-meshheading:9227453-...lld:pubmed
pubmed-article:9227453pubmed:meshHeadingpubmed-meshheading:9227453-...lld:pubmed
pubmed-article:9227453pubmed:meshHeadingpubmed-meshheading:9227453-...lld:pubmed
pubmed-article:9227453pubmed:meshHeadingpubmed-meshheading:9227453-...lld:pubmed
pubmed-article:9227453pubmed:meshHeadingpubmed-meshheading:9227453-...lld:pubmed
pubmed-article:9227453pubmed:meshHeadingpubmed-meshheading:9227453-...lld:pubmed
pubmed-article:9227453pubmed:meshHeadingpubmed-meshheading:9227453-...lld:pubmed
pubmed-article:9227453pubmed:meshHeadingpubmed-meshheading:9227453-...lld:pubmed
pubmed-article:9227453pubmed:meshHeadingpubmed-meshheading:9227453-...lld:pubmed
pubmed-article:9227453pubmed:year1997lld:pubmed
pubmed-article:9227453pubmed:articleTitleRegulation of plasma fatty acid oxidation during low- and high-intensity exercise.lld:pubmed
pubmed-article:9227453pubmed:affiliationMetabolism Unit, Shriners Burns Institute, Galveston, Texas 77550, USA.lld:pubmed
pubmed-article:9227453pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9227453pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9227453pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9227453lld:pubmed